Humana (HUM) Receives New Coverage from Analysts at Goldman Sachs Group
Goldman Sachs Group assumed coverage on shares of Humana (NYSE:HUM) in a research report report published on Wednesday morning. The brokerage issued a buy rating and a $305.00 target price on the insurance provider’s stock.
A number of other equities research analysts also recently weighed in on HUM. Cowen reaffirmed an outperform rating and issued a $275.00 target price (up previously from $230.00) on shares of Humana in a report on Wednesday, September 20th. Zacks Investment Research raised Humana from a hold rating to a buy rating and set a $273.00 target price on the stock in a report on Tuesday, October 3rd. JPMorgan Chase & Co. downgraded Humana from an overweight rating to a neutral rating and set a $253.00 target price on the stock. in a report on Monday, October 9th. ValuEngine cut Humana from a buy rating to a hold rating in a research note on Tuesday, October 10th. Finally, Royal Bank of Canada reiterated a hold rating and issued a $245.00 price target on shares of Humana in a research note on Tuesday, October 10th. Twelve equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company currently has an average rating of Buy and a consensus price target of $258.62.
Shares of Humana (NYSE HUM) traded up $7.08 during mid-day trading on Wednesday, hitting $258.36. The company’s stock had a trading volume of 1,346,100 shares, compared to its average volume of 1,125,867. The firm has a market cap of $37,620.00, a P/E ratio of 20.34, a PEG ratio of 1.66 and a beta of 0.88. Humana has a 52-week low of $186.25 and a 52-week high of $264.56. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.62%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is currently 12.60%.
Humana declared that its Board of Directors has initiated a stock buyback program on Thursday, December 14th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the insurance provider to repurchase shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its shares are undervalued.
In other Humana news, SVP Brian P. Leclaire sold 1,679 shares of the stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the sale, the senior vice president now directly owns 9,888 shares in the company, valued at approximately $2,432,151.36. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Jody L. Bilney sold 7,054 shares of the stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $247.89, for a total value of $1,748,616.06. Following the sale, the senior vice president now owns 11,704 shares of the company’s stock, valued at $2,901,304.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,115 shares of company stock valued at $2,501,627. 0.80% of the stock is owned by corporate insiders.
Institutional investors have recently modified their holdings of the business. Koch Industries Inc. acquired a new stake in Humana during the 2nd quarter worth about $404,000. Adviser Investments LLC acquired a new stake in Humana during the 3rd quarter worth about $635,000. Teachers Advisors LLC grew its holdings in Humana by 31.6% during the 2nd quarter. Teachers Advisors LLC now owns 630,835 shares of the insurance provider’s stock worth $151,792,000 after acquiring an additional 151,603 shares during the period. Wells Fargo & Company MN grew its holdings in Humana by 10.0% during the 3rd quarter. Wells Fargo & Company MN now owns 1,653,318 shares of the insurance provider’s stock worth $402,799,000 after acquiring an additional 150,173 shares during the period. Finally, Prisma Capital Partners LP acquired a new stake in shares of Humana in the 2nd quarter valued at about $7,122,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Humana (HUM) Receives New Coverage from Analysts at Goldman Sachs Group” was originally posted by Marea Informative and is the sole property of of Marea Informative. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.mareainformativa.com/2018/01/05/humana-hum-receives-new-coverage-from-analysts-at-goldman-sachs-group.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.